Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
Recruiting · NCT07293923 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Shock, Cardiogenic, cardiovascular disorder, heart disorder, heart failure, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-07-16 | NCT07293923 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Magenta Medical Ltd. | 3 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beilinson Medical Center | Petah Tikva | Israel | 1 |
| Israeli-Georgian Medical Research Clinic Helsicore | Tbilisi | Georgia | 2 |
| Meir Medical Center | Kfar Saba | Israel | 29 |
| Rambam Medical Center | Haifa | Israel | 19 |
| Shamir Medical Center | Be’er Ya‘aqov | Israel | 10 |
| Sheba Medical Center | Ramat Gan | Israel | 43 |
| Tbilisi Heart Center | Tbilisi | Georgia | 4 |
| Tel-Aviv Sourasky Medical Center | Tel Aviv | Israel | 7 |